Publication

Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma: an in vitro approach

Bibliographic Details
Main Authors:	Amaro, Filipa
Other Authors:	Pisoeiro, Carolina; Valente, Maria João; Miranda-Gonçalves, Vera; Jerónimo, Carmen; Henrique, Rui; Bastos, Maria de Lourdes; Guedes de Pinho, Paula; Carvalho, Márcia; Pinto, Joana
Subject:	renal cell carcinoma tyrosine kinase inhibitors antiproliferative cytotoxicity in vitro
Year:	2022
Country:	Portugal
Document type:	article
Associated institution:	Rede Académica das Ciências da Saúde da Lusofonia
Language:	English
Origin:	RevSALUS – Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofonia

Similar Items

Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
by: Zucca, Luís Eduardo
Published: (2018)

Green tea: a promising anticancer agent for renal cell carcinoma
by: Carvalho, Márcia
Published: (2010)

HER2-Targeted immunotherapy and combined protocols showed promising antiproliferative effects in feline mammary carcinoma cell-based models
by: Gameiro, Andreia
Published: (2021)

Tyrosine kinase inhibitors are promising therapeutic tools for cats with HER2-positive mammary carcinoma
by: Gameiro, Andreia
Published: (2021)

Kinase inhibitors in neurooncology
by: Mendes, Carolina Caetano
Published: (2021)

Anti-EGFR therapy: strategies in head and neck squamous cell carcinoma.
by: Oliveira-Silva, Renato J.
Published: (2016)

Effectiveness and safety of lenvatinib in a series of advanced well-differentiated thyroid carcinomas from a single tertiary cancer center and literature review
by: Damásio, Inês L
Published: (2025)

TAM pathway receptor proteins: differential expression in healthy human masticatory mucosa
by: Vavetsi, Konstantina
Published: (2025)

NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
by: Almeida, Jani Sofia
Published: (2019)

Generation of a small library of indole derivatives to target drug resistance in cancer
by: Janeiro, Ana Margarida Charrua
Published: (2025)

Metabolic reprogramming of sunitinib- and pazopanib-resistant renal cell carcinoma cells: a metabolomics approach
by: Amaro, E.
Published: (2023)

Real-world challenges in first-line treatment of metastatic EGFR-mutated non-small cell lung cancer
by: Barreto, Inês
Published: (2023)

New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives
by: De Mello, Ramon Andrade
Published: (2020)

Evaluation of the metabolomic response of renal cell carcinoma cells to sunitinib and pazopanib by NMR metabolomics
by: Carolina Beatriz Cunha Pisoeiro
Published: (2022)

Management of ibrutinib treatment in patients with B-cell malignancies: clinical practice in Portugal and multidisciplinary recommendations
by: Carda, JP
Published: (2021)

Management of ibrutinib treatment in patients with B-cell malignancies: clinical practice in Portugal and multidisciplinary recommendations
by: Carda, José Pedro
Published: (2021)

Real-world challenges in first-line treatment of metastatic EGFR-mutated non-small cell lung cancer
by: Barreto, Inês
Published: (2023)

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
by: Fontes-Sousa, M
Published: (2022)

Cardiotoxicity in haematological diseases : are the tyrosine kinase inhibitors imatinib and nilotinib safe?
by: Francisco, A. R. Gaspar Lopes
Published: (2017)

New prospects for the management of cardiovascular effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
by: Almeida, Ana G.
Published: (2019)

Therapeutic Options in Neuro-Oncology
by: Afonso, Mariana
Published: (2022)

Biological activities of portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro
by: Valente, Maria J.
Published: (2011)

Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach
by: Costa, D
Published: (2017)

TAM pathway proteins as novel salivary biomarkers for periodontitis
by: Mendes, Karina
Published: (2026)

Alectinib-induced anemia with acanthocytosis: To proceed or discontinue treatment in Non-Small Cell Lung Cancer patients?
by: Simões, Filipa
Published: (2024)

The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal
by: Coelho Barata, P
Published: (2018)

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: A network meta-analysis
by: Mello, R
Published: (2018)

The inhibitory potential of selected tyrosine kinase inhibitors on the most active anthracycline carbonyl reducing enzymes
by: Ganhão, João Miguel Gomes
Published: (2023)

Caso clínico – carcinoma da tireoide refratário ao iodo radioativo
by: Oliveira, Luís Ferreira de
Published: (2018)

Small bowel intussusception secondary to metastatic renal cell carcinoma: a case report
by: Barros, Pedro
Published: (2023)

Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach.
by: Costa, D
Published: (2018)

Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune-mediated dermatological conditions
by: Mendes-Bastos, Pedro
Published: (2022)

Antiproliferative and cytotoxic effect of abietane diterpenes in urothelial carcinoma cell line
by: Sousa, Ana Isabel Coelho de
Published: (2024)

Metachronous metastases to the thyroid gland from renal carcinoma
by: Toribio Ruano, Ignacio
Published: (2021)

Modulation of erythrocyte hemorheological properties by band 3 phosphorylation and dephosphorylation
by: Saldanha, Carlota
Published: (2007)

Giant Renal Chromophobe Carcinoma: Cromófobo Renal Gigante
by: Santos, Pedro Bargão
Published: (2017)

Selective cytotoxicity of Portuguese propolis ethyl acetate fraction towards renal cancer cells
by: Freitas, Ana Sofia
Published: (2022)

The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal
by: Barata, Pedro Coelho
Published: (2018)

Personalizing medicine for metastatic colorectal cancer: Current developments
by: Marques, Andrea Marin
Published: (2014)

Novel therapies against aggressive differentiated thyroid carcinomas
by: Donato, Sara
Published: (2018)